← Eichor
Condition: Secondary Hyperparathyroidism Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Secondary Hyperparathyroidism

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations
Phase N/A · 2 location(s) · University of Copenhagen · NCT07312981A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
Phase N/A · 1 location(s) · Boryung Pharmaceutical Co., Ltd · NCT06126016Genetics in the Progression of Nephropathies
Phase N/A · 1 location(s) · Ospedale San Raffaele · NCT06416761The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bon
NA · 1 location(s) · Herlev Hospital · NCT07171216Integrated Diagnosis and Treatment of CKD on Outcomes
Phase N/A · 1 location(s) · Capital Medical University · NCT05242055Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism
NA · 1 location(s) · The Second Hospital of Nanjing Medical University · NCT04922892Precision Medicine Approaches to Renal Osteodystrophy
Phase N/A · 1 location(s) · Thomas Nickolas · NCT05880914Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management
Phase N/A · 1 location(s) · Medical University of Gdansk · NCT06571344A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemo
Phase 3 · 43 location(s) · Amgen · NCT03633708Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease
Phase 2 · 1 location(s) · Shaanxi Micot Pharmaceutical Technology Co., Ltd. · NCT06976177Calcium Isotope Ratios to Assess Calcium Bone Balance in Dialysis Children Receiving Cinacalcet
Phase N/A · 7 location(s) · Hospices Civils de Lyon · NCT07007338A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Phase 3 · 23 location(s) · Amgen · NCT03969329Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism
Phase 3 · 1 location(s) · Shaanxi Micot Pharmaceutical Technology Co., Ltd. · NCT07122401Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients
Phase N/A · 1 location(s) · Grigore T. Popa University of Medicine and Pharmacy · NCT07141043Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
Phase 4 · 4 location(s) · Ditte Hansen · NCT04522622Activated Charcoal Use in Chronic Kidney Disease Patients
Phase 2 · 1 location(s) · Mansoura University · NCT06906874Parathyroid Tumor Clonal Status
Phase N/A · 1 location(s) · Washington University School of Medicine · NCT05997810Phosphate Assessment in Chronic Kidney Disease Patients Study
NA · 1 location(s) · University of Texas Southwestern Medical Center · NCT07368946Diagnosis of Renal Osteodystrophy in Patients With Reduced Renal Function
Phase N/A · 1 location(s) · Ditte Hansen · NCT03716128
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.